Development and Validation of HPLC method for simultaneous estimation of Rifampicin and Ofloxacin using experimental design

References

• World Health Organization. WHO global tuberculosis report. Geneva: WHO; 2016.
   Google Scholar
• Hall RG, Leff RD, Gumbo T. Treatment of active pulmonary tuberculosis in adults: current standards and recent advances. Pharmacother. 2009;29:1468–1481. doi: 10.1592/phco.29.12.1468
   PubMed Web of Science ®Google Scholar
• O’Neil MJ, editor. The merck index an encyclopedia of chemicals, drugs, and biologicals. 13th ed. Whitehouse Station (NJ): Merck and Co., Inc.; 2001. p. 1474.
   Google Scholar
• Maggi N, Pasqualucci CR, Ballota R, et al. Rifampicin: a new orally active rifamycin. Chemother. 1966;11:285–292. doi: 10.1159/000220462
   PubMed Web of Science ®Google Scholar
• Rees RJW, Pearson JMH, Waters MFR. Experimental and clinical studies on rifampicin in treatment of leprosy. Br Med J. 1970;1:89–92. doi: 10.1136/bmj.1.5688.89
   Google Scholar
• Binda G, Domenichini E, Gottardi A. Rifampicin, a general review. Arzneim Forsch. 1971;21:1907–1977.
   PubMed Web of Science ®Google Scholar
• Pähkla R, Lambert J, Ansko P, et al. Comparative bioavailability of three different preparations of rifampicin. J Clin Pharm Ther. 1999;24:219–225. doi: 10.1046/j.1365-2710.1999.00223.x
   PubMed Web of Science ®Google Scholar
• Tsankov N, Angelova I. Rifampin in dermatology. Clin Dermatol. 2003;21:50–55. doi: 10.1016/S0738-081X(02)00328-0
   PubMed Web of Science ®Google Scholar
• Rainbow J, Cebelinski E, Bartkus J, et al. Rifampin-resistant meningococcal disease. Emerg Infect Dis. 2005;11:977–979. doi: 10.3201/eid1106.050143
   PubMed Web of Science ®Google Scholar
• Ginsburg AS, Grosset JH, Bishai WR. Fluoroquinolones, tuberculosis, and resistance. Lancet Infect Dis. 2003;3:432–442. doi: 10.1016/S1473-3099(03)00671-6
   PubMed Web of Science ®Google Scholar
• Simpson KL, Markham A. Ofloxacin otic solution: a review of its use in the management of ear infections. Drugs. 1999;58:509–531. doi: 10.2165/00003495-199958030-00019
   PubMed Web of Science ®Google Scholar
• Jurado ER, Tudó G, Bellacasac JP, et al. In vitro effect of three-drug combinations of antituberculous agents against multidrug-resistant mycobacterium tuberculosis isolates. Int J Antimicrob Agents. 2013;41:278–280. doi: 10.1016/j.ijantimicag.2012.11.011
   Web of Science ®Google Scholar
• Jurado ER, Tudó G, Martinez JA, et al. Synergistic effect of two combinations of antituberculous drugs against mycobacterium tuberculosis. Tuberc. 2012;92:260–263. doi: 10.1016/j.tube.2012.01.005
   Google Scholar
• Dhal C, Ahmad FJ, Chauhan A, et al. Quality by design approach for simultaneous estimation of doxycycline hyclate and curcumin by RP-HPLC method. Indian J Pharm Sci. 2015;77:723–728. doi: 10.4103/0250-474X.174992
   PubMed Web of Science ®Google Scholar
• Jain P, Pathak VM. Development and validation of UV-visible spectrophotometric method for estimation of rifapentine in bulk and dosage form. Der Pharma Chemica. 2013;5:251–255.
   Google Scholar
• Tella ED, Sunitha S, Garikipati DK, et al. Assay of rifampicin in bulk and its dosage forms by visible spectrophotometry using chloranilic acid. IJCEE. 2012;3:64–67.
   Google Scholar
• Sriram ST, Prasanthi B, Tata S, et al. Development and validation of high performance liquid chromatographic method for the determination of rifampicin in human plasma. Int J Pharm Pharm Sci. 2012;4:362–367.
   Google Scholar
• Liua J, Suna J, Zhanga W, et al. HPLC determination of rifampicin and related compounds in pharmaceuticals using monolithic column. J Pharm Biomed Anal. 2008;46:405–409. doi: 10.1016/j.jpba.2007.10.025
   Web of Science ®Google Scholar
• Ali J, Ali N, Sultana Y, et al. Development and validation of a stability- indicating HPTLC method for analysis of antitubercular drugs. Acta Chromatographica. 2007;18:168.
   Web of Science ®Google Scholar
• Kapuriya KG, Parmar PM, Topiya HR, et al. Method development and validation of rifampicine and piperine in their combined dosage form. Int Bull Drug Res. 2012;1:71–80.
   Google Scholar
• Bhusari SS, Bhat V, Koul M, et al. Development and validation of a RP-HPLC method for the simultaneous determination of rifampicin and a flavonoid glycoside – a novel bioavailability enhancer of rifampicin. Trop J Pharm Res. 2009;8:531–537.
   Web of Science ®Google Scholar
• Yan H, Zhou Y, Xie Q, et al. Simultaneous analysis of isoniazid and rifampicin by high performance liquid chromatography with gradient elution and wall-jet/thin-layer electrochemical detection. Anal Methods. 2014;6:1530–1537. doi: 10.1039/c3ay41794h
   Web of Science ®Google Scholar
• Wankhede SB, Prakash A, Chitlange SS. Simultaneous reverse phase Hplc estimation of ofloxacin and satranidazole in tablet dosage form. Int J PharmTech Res. 2009;1:1136–1138.
   Google Scholar
• Sireesha KR, Prakash K. HPLC-UV method for simultaneous determination of ofloxacin and dexamethasone sodium phosphate. Int J Pharm Pharm Sci. 2012;4:415–418.
   Google Scholar
• Deekonda P, Reddy MS. Method development and validation for the quantitative estimation of cefixime and ofloxacin in pharmaceutical preparation by RP- HPLC. Der Pharma Chemica. 2014;6:31–37.
   Google Scholar
• Hallem RM, Salem MY, Fatahallah FA, et al. Quality in the pharmaceutical industry – a literature review. Saudi Pharm J. 2015;23:463–469. doi: 10.1016/j.jsps.2013.11.004
   Web of Science ®Google Scholar
• Srinubabu G, Raju CAI, Sarath N, et al. Development and validation of a HPLC method for the determination of voriconazole in pharmaceutical formulation using an experimental design. Talanta. 2007;71:1424–1429. doi: 10.1016/j.talanta.2006.04.042
   PubMed Web of Science ®Google Scholar
• Patel KG, Shah PM, Shah PA, et al. Validated high-performance thin-layer chromatographic (HPTLC) method for simultaneous determination of nadifloxacin, mometasone furoate, and miconazole nitrate cream using fractional factorial design. J Food Drug Anal. 2016;24:610–619. doi: 10.1016/j.jfda.2016.02.011
   PubMed Web of Science ®Google Scholar
• International Conference on Harmonization. ICH Q2 (R1): validation of analytical procedures: text and methodology, ICH Secretariat, Geneva, 2005.
   Google Scholar
• United States Pharmacopeia 27, national formulary 22, vol.2, The United States Pharmacopoeial Convention, Rockville, 2003. p. 2281.
   Google Scholar
• Zar JH. Biostatistical analysis. 5th ed Upper saddle River (NJ): Pearson Educational Publications; 2010.
   Google Scholar
• Kleinschmidt G. Method validation in pharmaceutical analysis. In: Ermer J, Miller JHM, editor. A guide to best practice. Weinheim: Wiley-VCH Verlag GmbH and Co. KGaA; 2005. p.70.
   Google Scholar
• Annapurna MM, Mohapatro C, Narendra A. Stability-indicating liquid chromatographic method for the determination of Letrozole in pharmaceutical formulations. J Pharm Anal. 2012;2:298–305. doi: 10.1016/j.jpha.2012.01.010
   PubMedGoogle Scholar